APP and Alzheimer disease: More importantly, Dyrk1A interacts with the Alzheimer's disease (AD)-causing proteins tau and amyloid precursor protein acting as priming kinase (11, 12), and this kinase has thus been implicated in the widespread appearance of AD symptoms in mouse models and humans with DS (13, 14).